Declaration Of Compliance With The German Sustainability Code Dnk And Non-Financial Statement

Overview

The report describes Biotest Group's 2021 sustainability performance across its plasma-based pharmaceutical value chain. Group energy consumption including Biotest Next Level was 117,816 MWh, while 10,246 tonnes of commercial waste were generated and 86% was materially utilised or recycled. Biotest reported CO2 neutrality for Scope 1 and 2 through renewable electricity and compensation, with complete Group climate neutrality targeted by 2035. It also disclosed EU Taxonomy KPIs, including 3.70% eligible CapEx and 2.50% eligible OpEx.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview